Munich Re gives its views on the early stage cancer debate as part of the ABI's CI Statement of Best Practice consultation.
History shows that well established markets often come to a crossroads where changes are made. Competitive pressures inevitably drive more product options, quicker new business processes and put pressure on claims decisions, while prices get cheaper…something eventually has to give. Such pressure is building within the UK Critical Illness (CI) market and questions are being asked as to how we should proceed. This is not the first time that CI has been at such a crossroads: in 2002 a major...
Our biggest Protection & Health Summit yet comes to Hilton London Bankside on 4 October
Departure of managing director behind 'Rewire Routines' campaign opens two new roles alongside other key changes
Those caring for children and older relatives are under financial strain, research finds
How group income protection policies can offer legal support to business owners